INR 270.4
(-0.93%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 294.08 Million | 290.79 Million | 165.5 Million | 109.01 Million | 288.79 Million | 154.88 Million |
Net Income | 268.45 Million | 345.92 Million | 225.42 Million | 151.42 Million | 390.94 Million | 442.04 Million |
Depreciation & Amortization | 11.77 Million | 12.72 Million | 11.4 Million | 12.35 Million | 10.05 Million | 11.78 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 13.35 Million | 13.52 Million | -8.08 Million | 14.24 Million | -7.49 Million | -89.68 Million |
Other non-cash items | 5.74 Million | -81.37 Million | -63.24 Million | -69.01 Million | -104.7 Million | -209.25 Million |
Investing Cash Flow | -297.59 Million | -248.88 Million | -155.2 Million | 245.55 Million | -343.24 Million | -321.48 Million |
Investments in PPE | -6.31 Million | -10.53 Million | -1.33 Million | -1.55 Million | -990.45 Thousand | -4.76 Million |
Acquisitions | 85 Thousand | 1.9 Million | 2.06 Million | 2.02 Million | 10 Thousand | 126.59 Million |
Investment purchases | -542.26 Million | -500.7 Million | -171.57 Million | -11.29 Million | -345.04 Million | -455.66 Million |
Sales/Maturities of investments | 250.89 Million | 260.44 Million | 15.63 Million | 256.38 Million | 76.28 Thousand | 9.79 Million |
Other Investing Activities | 5000.00 | 4000.00 | 4000.00 | 4000.00 | 2.69 Million | 2.55 Million |
Financing Cash Flow | -5.25 Million | -6.34 Million | -8.4 Million | -332.19 Million | 358.43 Thousand | -15.44 Million |
Debt repayment | -5.25 Million | -5.08 Million | -5.64 Million | -1.43 Million | -10.45 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -7.81 Million | -291.15 Million | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -5.25 Million | -6.34 Million | -595 Thousand | -39.59 Million | 10.81 Million | -15.44 Million |
Accounts receivables | -626 Thousand | -522 Thousand | 1.08 Million | 3.03 Million | -4.44 Million | 1.82 Million |
Accounts payables | 198 Thousand | 14.69 Million | 4.85 Million | -17.09 Million | 4.11 Million | 28.15 Million |
Inventory | 18.73 Million | -14.61 Million | -16.7 Million | 31.28 Million | -162.15 Thousand | -37.69 Million |
Other working capital | -4.95 Million | 13.97 Million | 2.68 Million | -2.97 Million | -7 Million | -81.96 Million |
Cash at beginning of period | 78.75 Million | 27.95 Million | 26.06 Million | 3.68 Million | 57.77 Million | 239.82 Million |
Cash at end of period | 105.28 Million | 63.53 Million | 27.95 Million | 26.06 Million | 3.67 Million | 57.77 Million |
Capital Expenditure | -6.31 Million | -10.53 Million | -1.33 Million | -1.55 Million | -990.45 Thousand | -4.76 Million |
Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
Net cash flow / Change in cash | 26.53 Million | 35.57 Million | 1.89 Million | 22.38 Million | -54.09 Million | -182.05 Million |
Free Cash Flow | 287.77 Million | 280.26 Million | 164.16 Million | 107.46 Million | 287.8 Million | 150.11 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 46.06 Million | 268.45 Million | 47.77 Million | 68.62 Million | 87.26 Million | 64.79 Million |
Depreciation & Amortization | - | 11.77 Million | - | 3.44 Million | - | 3.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 13.35 Million | - | - | - | - |
Other non-cash items | -46.06 Million | 5.74 Million | -47.77 Million | -68.62 Million | -87.26 Million | -64.79 Million |
Investing Cash Flow | - | -297.59 Million | - | - | - | - |
Investments in PPE | - | -6.31 Million | - | - | - | - |
Acquisitions | - | 85 Thousand | - | - | - | - |
Investment purchases | - | -542.26 Million | - | - | - | - |
Sales/Maturities of investments | - | 250.89 Million | - | - | - | - |
Other Investing Activities | - | 5000.00 | - | - | - | - |
Financing Cash Flow | - | -5.25 Million | - | - | - | - |
Debt repayment | - | -5.25 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -5.25 Million | - | - | - | - |
Accounts receivables | - | -626 Thousand | - | - | - | - |
Accounts payables | - | 198 Thousand | - | - | - | - |
Inventory | - | 18.73 Million | - | - | - | - |
Other working capital | - | -4.95 Million | - | - | - | - |
Cash at beginning of period | - | 78.75 Million | - | - | - | 78.75 Million |
Cash at end of period | - | 105.28 Million | - | 6.88 Million | - | 64.79 Million |
Capital Expenditure | - | -6.31 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 26.53 Million | - | 6.88 Million | - | -13.95 Million |
Free Cash Flow | - | 287.77 Million | - | 6.88 Million | - | 64.79 Million |
2440
REGENCERAM
DJML
RICY
SYMBIOX
ACME